Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
10.1034/j.1399-3003.2000.016003534.x Eur Respir J
The body handles ordinary demands, a stressful week, a drink with dinner, a seasonal illness, without falling significantly behind
, , , , , ,
FDA-Noted Concerns: Increased heart rate Systemic vasodilatory reactions Limited clinical safety data Immunogenicity risk (antibody formation) Reported Side Effects: Injection site reactions (redness, swelling, itching) Headache Flushing Dizziness Nausea Water retention Serious Concerns: Potential for glucose metabolism disruption Theoretical cancer risk (GH/IGF-1 promote cell proliferation) Long-term safety unknown Regulatory Status United States: CJC-1295 is not FDA approved for any indication
US$ 22.43
US$ 25.69
US$ 23.23
US$ 26.93
US$ 23.34
